One hundred and fifteen patients, separated into 4 groups, received neostigmine 5 mg with either atropine 1.2 mg or 1.8 mg, or glycopyrrolate 0.6 mg or 0.9 mg. Those receiving 0.9 mg glycopyrrolate had insignificant changes in heart rate in the immediate postreversal period. It is recommended that when glycopyrrolate is used with 5 mg neostigmine, the optimum dose is 0.9 mg.
References
1.
GriffithHRJohnsonGE.The use of curare in general anaesthesia. Anesthesiology1942; 3: 418–20.
2.
ShaneMSCamdenDDS. Curare - a complement to anesthesia. Anesth Analg1945; 24: 256–8.
3.
LenahanNE.Use of curare in genito-urinary surgery. Urol Cutan Rev1945; 49: 151–2.
4.
HoladayDA.Nitrous oxide-cyclopropane-curare anesthesia; a review of 200 cases. Anesthesiology1946; 7: 426–40.
5.
PallinIM.Curare in the poor anesthetic risk patient. NY State J Med1946; 46: 2523–9.
6.
GrayTCHaltonJ.A milestone in anaesthesia? (d-tubocurarine chloride). Proc R Soc Med1946; 39: 400–8.
7.
PalJ.Physostigmin ein gegengist des curare. Zbl Physiol1900; 14: 255–8. (Analgesia 1945;24:256–8).
8.
AeschlimannJAReinhertM.Pharmacological action of some analogues of physostigmine. J Pharmacol Exp Ther1931; 43;413–44.
9.
TaylorP.Anticholinesterase agents. In: GilmanAGGoodmanLSGilmanA, eds. The Pharmacological Basis of Therapeutics. New York: Macmillan, 1980: 100–19.
10.
RemenL.Zur pathogenese und therapie der myasthenia gravis pseudoparalytic. Dtsch Z Nervenheilk1932;128:66–78.
11.
WalkerMB.Case showing the effect of Prostigmin on myasthenia gravis. Proc R Soc Med1935; 28: 759–61.
12.
KoppaniTVivinoAE.Prevention and treatment of d-tubocurarine poisoning. Science1944; 100: 474–5.
13.
BurkeJCLinegarCR.Eserine and neostigmine antagonism to d-tubocurarine. Anesthesiology1948; 9: 251–7.
14.
GrayTC.A system of anaesthesia using d-tubocurarine chloride for chest surgery. Postgrad Med J1948; 14: 516–28.
15.
BridenbaughPOChurchill-DavidsonHC.Response to tubocurarine chloride and its reversal by neostigmine methylsulphate in man. JAMA1968;203:541–4.
16.
Viby-MogensenJJorgensenBCOrdingH.Residual curarization in the recovery room. Anesthesiology1979; 50: 539–41.
17.
MirakhurRKDundeeJWClarkeRSJ. Glycopyrrolate-neostigmine for antagonism of neuromuscular block: Comparison with atropine-neostigmine mixture. Br J Anaes1977; 49: 825–9.
18.
MirakhurRKDundeeJWJonesCJCoppelDLClarkeRSJ. Reversal of neuromuscular blockade: Dose determination studies with atropine and glycopyrrolate given before or in a mixture with neostigmine. Anesth Analg1981; 60: 557–62.
19.
KongsrudFSponheimS.A comparison of atropine and glycopyrrolate in anaesthetic practice. Acta Anaesthesiol Scand1982; 26: 620–5.
20.
MirakhurRKDundeeJW.Glycopyrrolate: Pharmacology and clinical use. Anaesthesia1983; 38: 1195–204.
21.
MirakhurRKDundeeJW.Comparison of the effects of atropine and glycopyrrolate on various end-organs. J R Soc Med1980; 73: 727–30.
22.
GreenhouseSWGeisserR.On methods in the analysis of profile data. Psychometrika1954; 24: 95–112.
23.
BlittCDMoonBJKartchnerCD.Duration of action of neostigmine in man. Can Anaesth Soc J1976; 23: 80–4.
24.
ProakisAGHarrisGB.Comparative penetration of glycopyrrolate and atropine across the blood-brain and placental barriers in anesthetized dogs. Anesthesiology1978; 48: 339–44.
25.
BarakaAYaredJKaramAWinnieA.Glycopyrrolate-neostigmine and atropine-neostigmine mixtures affect postanesthetic arousal times differently. Anesth Analg1980; 59: 431–4.
